| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 80.538 | 216.410 | 219.153 | 216.638 | 340.170 | 194.343 |
| Total Income - EUR | - | - | - | - | 80.590 | 216.925 | 221.517 | 218.191 | 342.969 | 195.366 |
| Total Expenses - EUR | - | - | - | - | 58.221 | 195.942 | 212.026 | 201.228 | 344.979 | 196.022 |
| Gross Profit/Loss - EUR | - | - | - | - | 22.370 | 20.983 | 9.491 | 16.963 | -2.010 | -656 |
| Net Profit/Loss - EUR | - | - | - | - | 20.789 | 19.095 | 7.937 | 14.796 | -2.010 | -656 |
| Employees | - | - | - | - | 1 | 1 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Audubon Bioscience S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 3.814 | 11.978 | 12.000 | 9.584 | 7.175 | 7.491 |
| Current Assets | - | - | - | - | 22.686 | 41.361 | 46.730 | 72.187 | 117.175 | 92.558 |
| Inventories | - | - | - | - | 473 | 0 | 0 | 68 | 131 | 481 |
| Receivables | - | - | - | - | 4.546 | 37.347 | 21.386 | 34.332 | 100.225 | 76.723 |
| Cash | - | - | - | - | 17.667 | 4.013 | 25.343 | 37.787 | 16.819 | 15.355 |
| Shareholders Funds | - | - | - | - | 20.831 | 39.531 | 46.592 | 61.533 | 59.336 | 58.349 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 6.389 | 13.808 | 12.138 | 20.239 | 65.014 | 41.700 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Audubon Bioscience S.r.l.